Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (311-320 of 522) with videos related to

Pageof 53
Sort By:
Urology|July 24, 2017
Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical RecurrenceStephanie L Skove, Lauren E Howard, William J Aronson, et al.
Urology Practice|August 10, 2023
Updated Survey of Social Media Use by Members of the American Urological AssociationStacy Loeb, Christopher E Bayne, Christine Frey, et al.
Cancer|October 21, 2015
Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital DatabaseBrian T Hanyok, Lauren E Howard, Christopher L Amling, et al.
Scientific Reports|July 17, 2023
Explainable ML models for a deeper insight on treatment decision for localized prostate cancerJang Hee Han, Sungyup Lee, Byounghwa Lee, et al.
European Urology Focus|July 30, 2017
In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH DatabaseColette A Whitney, Lauren E Howard, Edwin M Posadas, et al.
BJU International|May 27, 2015
Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?Ross M Simon, Lauren E Howard, Stephen J Freedland, et al.
The Journal of Urology|February 3, 2015
Current Use of Imaging after Primary Treatment of Prostate CancerAhmed A Hussein, Sanoj Punnen, Shoujun Zhao, et al.
BJU International|March 10, 2018
Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseAdriana C Vidal, Lauren E Howard, Amanda de Hoedt, et al.
The Journal of Urology|March 11, 2005
The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE)Jason W Anast, Natalia Sadetsky, David J Pasta, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 12, 2017
Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomyRoss M Simon, Lauren E Howard, Daniel M Moreira, et al.
Pageof 53

Showing results (311-320 of 522) with videos related to

Sort By:
Pageof 53
Urology|July 24, 2017
Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical RecurrenceStephanie L Skove, Lauren E Howard, William J Aronson, et al.
Urology Practice|August 10, 2023
Updated Survey of Social Media Use by Members of the American Urological AssociationStacy Loeb, Christopher E Bayne, Christine Frey, et al.
Cancer|October 21, 2015
Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital DatabaseBrian T Hanyok, Lauren E Howard, Christopher L Amling, et al.
Scientific Reports|July 17, 2023
Explainable ML models for a deeper insight on treatment decision for localized prostate cancerJang Hee Han, Sungyup Lee, Byounghwa Lee, et al.
European Urology Focus|July 30, 2017
In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH DatabaseColette A Whitney, Lauren E Howard, Edwin M Posadas, et al.
BJU International|May 27, 2015
Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?Ross M Simon, Lauren E Howard, Stephen J Freedland, et al.
The Journal of Urology|February 3, 2015
Current Use of Imaging after Primary Treatment of Prostate CancerAhmed A Hussein, Sanoj Punnen, Shoujun Zhao, et al.
BJU International|March 10, 2018
Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseAdriana C Vidal, Lauren E Howard, Amanda de Hoedt, et al.
The Journal of Urology|March 11, 2005
The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE)Jason W Anast, Natalia Sadetsky, David J Pasta, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 12, 2017
Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomyRoss M Simon, Lauren E Howard, Daniel M Moreira, et al.
Pageof 53